MetLife (MET)
(Delayed Data from NYSE)
$81.79 USD
+0.01 (0.01%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $81.78 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$81.79 USD
+0.01 (0.01%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $81.78 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth C Momentum B VGM
Zacks News
Here's Why You Should Add Assurant (AIZ) to Your Portfolio
by Zacks Equity Research
Assurant (AIZ) rides on operational excellence and promises better rewards for investors.
MetLife (MET) Gains As Market Dips: What You Should Know
by Zacks Equity Research
MetLife (MET) closed at $43.72 in the latest trading session, marking a +0.81% move from the prior day.
CNO Financial's Subsidiaries Get Ratings From A.M. Best
by Zacks Equity Research
CNO Financial's (CNO) arms receive rating actions from A.M. Best. Outlook is stable.
Why MetLife (MET) is Worth Adding to Your Portfolio Now
by Zacks Equity Research
Business streamlining and a solid balance sheet poise MetLife for growth in 2019.
Zacks.com featured expert Kevin Matras highlights: Gulfport Energy, MetLife, Fiat Chrysler Automobiles, CVS Health and Barclays
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Gulfport Energy, MetLife, Fiat Chrysler Automobiles, CVS Health and Barclays
5 Best GARP Picks with Discounted PEG
by Zacks Equity Research
To make a long-term investment more effective, the principles of both value and growth investing need to be combined.
Why Hold Strategy is Apt for Aon (AON) in Your Portfolio
by Zacks Equity Research
Backed by top-line growth, strategic endeavors and a solid cash trunk, Aon (AON) holds great potential to earn good returns for investors.
Zacks.com featured expert Kevin Matras highlights: Tech Data, ArcBest, MetLife, Gulfport Energy and Colfax
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Tech Data, ArcBest, MetLife, Gulfport Energy and Colfax
Is MetLife (MET) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (MET) Outperforming Other Finance Stocks This Year?
6 Promising Price-to-Book Value Stocks to Buy Now
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects.
Cigna (CI) & Units Receive Rating Actions From A.M. Best
by Zacks Equity Research
Credit rating giant A.M. Best affirms the ratings of Cigna (CI) and its subsidiaries.
Create a Value-Based Portfolio With These 5 Low P/CF Stocks
by Zacks Equity Research
One of the important factors that make P/CF a highly dependable metric is that operating cash flow adds back non-cash charges.
CME Group Gains 26% in a Year: Will the Rally Continue?
by Zacks Equity Research
Shares of CME Group (CME) rally 26.1% in a year, backed by solid fundamentals and initiatives to ramp up growth.
Why You Should Add Radian Group (RDN) to Your Portfolio
by Zacks Equity Research
Radian Group (RDN) rides on operational excellence and promises better rewards for investors.
Why You Should Add Brown & Brown (BRO) to Your Portfolio
by Zacks Equity Research
Brown & Brown (BRO) promises better reward for investors on operational excellence.
AIG's UK Unit Closes Buyout of Ellipse, Boosts Portfolio
by Zacks Equity Research
AIG's UK arm completes the pending purchase of Ellipse to strengthen its position in Life & Retirement businesses.
MGIC Investment New Business Written Growth Momentum Sustains
by Zacks Equity Research
Lower paid claims, solid new business written, better insurance in force and a firm capital position enable MGIC Investment (MTG) to emerge as a profitable pick for yield-seeking investors.
5 High Yielding S&P 500 Stocks to Buy for a Volatile 2019
by Nilanjan Choudhury
As we head into a period of high volatility in 2019, we have shortlisted five large-cap, dividend-paying companies to generate consistent cash distributions from the portfolio.
Should Value Investors Buy MetLife (MET) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Value Trader Highlights: Citigroup, Huntsman, Macy???s, MetLife and Apple
by Zacks Equity Research
Zacks Value Trader Highlights: Citigroup, Huntsman, Macy???s, MetLife and Apple
Where to Find Stocks on Sale
by Tracey Ryniec
The largest stock market sell-off in 10 years has created a buying opportunity if you know where to look.
7 Low Price-to-Sales Stocks to Invest in for Solid Returns
by Zacks Equity Research
A stock with a price-to-sales below 1 is a good bargain, as investors need to pay less than a dollar for a dollar's worth.
Is AIG Doomed to Have a Terrible 2019 Too?
by Sapna Bagaria
A challenging property and casualty market, exposure to catastrophes, little gain on restructuring initiatives will keep the stock of AIG under pressure.
Top Ranked Value Stocks to Buy for December 26th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 26th:
Zacks.com featured highlights include: General Motors, MetLife, Echo Global, Barclays and CAI
by Zacks Equity Research
Zacks.com featured highlights include: General Motors, MetLife, Echo Global, Barclays and CAI